Person:
ERİŞ, ALİ HİKMET

Loading...
Profile Picture
Status
Kurumdan Ayrılmıştır
Organizational Units
Organizational Unit
Job Title
First Name
ALİ HİKMET
Last Name
ERİŞ
Name
Email Address
Birth Date

Search Results

Now showing 1 - 10 of 10
  • PublicationMetadata only
    Thermal and Biochemical Effects of Low Level Electromagnetic Radiation on Rat Brains and Bodies
    (2014-06-01) KIZILTAN, HURİYE ŞENAY; ERİŞ, ALİ HİKMET; MAYADAĞLI, ALPASLAN; GÜNEŞ BAYIR, AYŞE; YAGCI, B; TAŞPINAR, ÖZGÜR; AYDIN, TEOMAN; TRABZON, M; KIZILTAN, HURİYE ŞENAY; ERİŞ, ALİ HİKMET; MAYADAĞLI, ALPASLAN; GÜNEŞ BAYIR, AYŞE; AYDIN, TEOMAN
  • PublicationMetadata only
    Pain management with Radiotherapy and ozone with high dose vitamin C therapy in a case of bone metastatis of breast cancer patient
    (2018-02-01) KIRSEVER, ESRA; KIZILTAN, HURİYE ŞENAY; YILMAZ, RABİYE; GÜNEŞ BAYIR, AYŞE; BAŞIBÜYÜK, MERYEM; ÇAKIR, FATMA BETÜL; GÜL, KÜRŞAT; ŞİMŞEK, MUHARREM; KIZILTEPE, AYŞE; GÜMÜŞ, ASLI; KALAYCI, KÜBRA; AKÇAKAYA, ADEM; MAYADAĞLI, ALPASLAN; AYDOĞDU, İBRAHİM; ALTINOK SÜT, PELİN; AYDIN, TEOMAN; KIZILTAN, HURİYE ŞENAY; ERİŞ, ALİ HİKMET; GÜNEŞ BAYIR, AYŞE; BAŞIBÜYÜK, MERYEM; ÇAKIR, FATMA BETÜL; GÜL, KÜRŞAT; GÜMÜŞ, ASLI; KALAYCI, KÜBRA; AKÇAKAYA, ADEM; MAYADAĞLI, ALPASLAN; AYDOĞDU, İBRAHİM; ALTINOK SÜT, PELİN; AYDIN, TEOMAN
  • PublicationOpen Access
    Outcome of Daily Cisplatin with Thoracic Chemoradiotherapy in Advanced Non-small Cell Lung Cancer Patients with Comorbid Disorders: a Pilot Study
    (2014-01-01) Kiziltan, HURİYE ŞENAY; Bayir, Ayse Gunes; TAŞTEKİN, Didem; Coban, GANİME; Eris, ALİ HİKMET; Aydin, TEOMAN; MAYADAGLI, Alparslan; KIZILTAN, HURİYE ŞENAY; GÜNEŞ BAYIR, AYŞE; ÇOBAN, GANİME; ERİŞ, ALİ HİKMET; AYDIN, TEOMAN; MAYADAĞLI, ALPASLAN
    Background: Lung cancer is the most common cancer in males worldwide. The principal mode of treatment in the early stage of non-small cell lung cancer (NSCLC) is surgery. However, five-year survival is only about 15% for all stages. The aim is to investigate the effect of daily low dose cisplatin concurrently with radiation therapy in advanced NSCLC patients with poor performance status. Materials and Methods: Ten patients diagnosed as inoperable Stage IIIB NSCLC with comorbid disease were assessed retrospectively in Bezmialem Vakif University, Faculty of Medicine, Department of Radiation Oncology, between 2011 to 2013. ECOG performance status was between 3 and 4. Cisplatin was administered at 6mg/m2 daily, for 5 days a week concurrently with radiotherapy using 160-200 cGy daily fractions, 54 Gy being the lowest and 63 Gy being the highest dose. Results: Complete response at the primary tumour site was obtained in 20% patients. Grade I esophagitis was seen 70 percent of patients, and the grade II haematological toxicity rate was 20 %. Median survival time was 7 months. Conclusions: Median survival time was reasonable, despite the patients ECOG performance status of 3-4, which is similar to groups even without comorbid disorders in comparison to other published papers in the literature. Acceptable toxicity, high response rates and quality of life of patients are the other favourable features.
  • PublicationMetadata only
    Medical ozone and radiotherapy in a peritoneal, erlich-ascites, tumor-cell model
    (2015-01-01) KIZILTAN, HURİYE ŞENAY; BAYIR, Ayşe Güneş; Yucesan, GÜL; Eris, ALİ HİKMET; KARATOPRAK, CUMALİ; İDİN, Kadir; AYDIN, TEOMAN; AKÇAKAYA, ADEM; MAYADAĞLI, ALPASLAN; KIZILTAN, HURİYE ŞENAY; GÜNEŞ BAYIR, AYŞE; YÜCESAN, GÜL; ERİŞ, ALİ HİKMET; KARATOPRAK, CUMALİ; AYDIN, TEOMAN; AKÇAKAYA, ADEM; MAYADAĞLI, ALPASLAN
  • PublicationMetadata only
    A First In Turkey, Palliative Care Unit At Bezmialem Vakif University Hospital
    (2016-03-11) BAŞIBÜYÜK, MERYEM; Kınık, Çiğdem; KIZILTAN, HURİYE ŞENAY; GÜL, KÜRŞAT; ERİŞ, ALİ HİKMET; AKÇAKAYA, ADEM; BAŞIBÜYÜK, MERYEM; KIZILTAN, HURİYE ŞENAY; GÜL, KÜRŞAT; ERİŞ, ALİ HİKMET; AKÇAKAYA, ADEM
  • PublicationMetadata only
    Successfull Pain Management with Radiotherapy and Ozone Therapy in a Case of Metastatic, Chemotherapy Resistant Sino-Nasal Mucosal Malignant Melanoma
    (2017-03-01) KIZILTAN, HURİYE ŞENAY; GÜNEŞ BAYIR, AYŞE; ERİŞ, ALİ HİKMET; BAŞIBÜYÜK, MERYEM; MAYADAĞLI, ALPASLAN; AKÇAKAYA, ADEM; ÇAKIR, FATMA BETÜL; AYDIN, TEOMAN; GÜL, KÜRŞAT; KARABAL, ESRA; ŞİMŞEK, MUHARREM; KIZILTAN, HURİYE ŞENAY; GÜNEŞ BAYIR, AYŞE; ERİŞ, ALİ HİKMET; BAŞIBÜYÜK, MERYEM; MAYADAĞLI, ALPASLAN; AKÇAKAYA, ADEM; ÇAKIR, FATMA BETÜL; AYDIN, TEOMAN; GÜL, KÜRŞAT; KARABAL, ESRA
  • PublicationMetadata only
    Düşük doz radyoterapi volümlerinin akciğer kanseri hastalarında yaşam üzerine etkileri
    (2017-07-01) KIZILTAN, HURİYE ŞENAY; MAYADAĞLI, ALPASLAN; ERİŞ, ALİ HİKMET; KABLAN, ÖZGÜR; EROĞUZ, SEZGİ TURAN; EVRİM, EVREN; ALTINOK SÜT, PELİN; TEKÇE, ERTUĞRUL; GÜNEŞ BAYIR, AYŞE; KIRSEVER, ESRA; KIZILTAN, HURİYE ŞENAY; MAYADAĞLI, ALPASLAN; ERİŞ, ALİ HİKMET; KABLAN, ÖZGÜR; ALTINOK SÜT, PELİN; TEKÇE, ERTUĞRUL; GÜNEŞ BAYIR, AYŞE
  • PublicationMetadata only
    Radioprotectant and Cytotoxic Effects of Spirulina in Relapsed Verrucous Vulvar Cancer: A Case Report
    (2015-01-01) Kiziltan, HURİYE ŞENAY; Bayir, Ayse Gunes; TAŞPINAR, Ozgur; Yucesan, GÜL; Tastekin, Didem; SONMEZ, Fatma Cavidan; Coban, GANİME; Kilic, GÖKHAN; Eris, ALİ HİKMET; Aydin, TEOMAN; Akcakaya, ADEM; Mayadagli, ALPASLAN; KIZILTAN, HURİYE ŞENAY; GÜNEŞ BAYIR, AYŞE; YÜCESAN, GÜL; ÇOBAN, GANİME; KILIC, GÖKHAN; ERİŞ, ALİ HİKMET; AYDIN, TEOMAN; AKÇAKAYA, ADEM; MAYADAĞLI, ALPASLAN
    Context . The treatment of relapsed verrucous vulvar cancer (VVC) is difficult. When vulvar cancer relapses, the treatment response is low for second-line treatments. Conversely, toxicity is high. Therefore, scientists need to identify different treatment methods.
  • PublicationMetadata only
    Can Nigella Sativa and Pure Honey Improved Chemoradiotherapy Effects in Advanced Pancreatic Cancer
    (2017-12-01) KIZILTAN, HURİYE ŞENAY; KÜRŞAT, TÜRKDOĞAN; GÜNEŞ BAYIR, AYŞE; ERİŞ, ALİ HİKMET; MAYADAĞLI, ALPASLAN; KIZILTAN, HURİYE ŞENAY; GÜNEŞ BAYIR, AYŞE; ERİŞ, ALİ HİKMET; MAYADAĞLI, ALPASLAN
  • PublicationMetadata only
    Peri-operative radiotherapy for the prevention of post -operative fibrosis on rats
    (2018-10-01) KIZILTAN, HURİYE ŞENAY; ERIS, ALİ HİKMET; MERAL, İSMAİL; SEYİTHANOĞLU, HAKAN; DÜNDAR, TOLGA TURAN; EREN, FATMA; ÜNVER, NURCAN; AYDIN, TEOMAN; MAYADAGLı, ALPASLAN; KIZILTAN, HURİYE ŞENAY; ERİŞ, ALİ HİKMET; MERAL, İSMAİL; SEYİTHANOĞLU, MEHMET HAKAN; DÜNDAR, TOLGA TURAN; ÜNVER, NURCAN; AYDIN, TEOMAN; MAYADAĞLI, ALPASLAN
    Background: Post-operative fibrosis related pains and functional anomalies can be serious problems for patients. Radiotherapy (RT) could inhibit fibrosis which may occurs post- operation especially following laminectomy. Therefore, this study was designed to investigate the effect of peri-operative RT on the prevention of post-operative fibrosis and scar formation on rats. Materials and Methods: Twenty three male Wistar albino rats, were divided into three experimental groups. Laminectomy was performed to L3 and L4 lomber vertebral regions of group L and L+R rats. The rats in L+R group in addition to this procedure also received ped-operative RT on the laminectomy area. A total dose of 700 cGy of RT was applied as a single fraction using electrons. Control rats received no treatment. A rotarod test was performed at 20, 30 and 40 rpm/min speed rates to determine the physical performances of the rats. Results: The results have indicated statistically significant (P<0.05) differences for the 30 rpm/min rotarod test between the L and L+R groups. Histopatologically, significant differences were observed in epidural fibrosis, fibroblast cell density and arachnoid adhesion between the L and L+R groups. Conclusion: It was concluded that ped-operative RT may provide a significant advantage for prevention post-laminectomic of scar tissue formation.